Hanada K, Kobayashi K. Invariant natural killer T cell–based immunotherapy using alpha-galactosylceramide–pulsed CD14+ monocytes for advanced gallbladder cancer. EJCRIM [Internet]. 2026 Jul. 13 [cited 2026 Nov. 3];13(8). Available from: https://ejcrim.com/index.php/ejcrim/article/view/7198